indian pharma
Jump to
13 Results Found
  • Coronavirus pandemic opens up a huge opportunity for Indian pharma Apr 14, 2020 08:53 AM IST

    Coronavirus pandemic opens up a huge opportunity for Indian pharma

    Local drug companies should address some of the longer term issues concerning the industry such as quality and good manufacturing practices

  • Reporter's Take | COVID-19 could be India’s chance to end reliance on China for drug raw material Mar 02, 2020 09:12 PM IST

    Reporter's Take | COVID-19 could be India’s chance to end reliance on China for drug raw material

    Moneycontrol's Shraddha Sharma talks to Viswanath Pilla to understand the problem of drug shortage in Indian pharmacy due to slowdown in China production.

  • Will India use coronavirus as an opportunity to end dependence on Chinese drug raw materials? Mar 01, 2020 11:02 AM IST

    Will India use coronavirus as an opportunity to end dependence on Chinese drug raw materials?

    Indian pharma companies import raw materials like key starting materials, intermediates and bulk drugs worth $4.5 billion

  • Indian Pharma exports to USA may go up in 2017-18: Report Jul 17, 2017 04:11 PM IST

    Indian Pharma exports to USA may go up in 2017-18: Report

    "The Indian pharmaceutical industry is likely to face competition from other countries to get ANDA (Abbreviated New Drug Application) approval. Apart from this, the Indian pharma companies will continue to witness pricing pressure in the US generics market due to consolidation of distribution channels and increase in competition.

  • Pfizer's Hospira receives 11 FDA observations for Vizag unit Mar 24, 2017 09:12 PM IST

    Pfizer's Hospira receives 11 FDA observations for Vizag unit

    An inspection by the US Food and Drug Administration took place at the sterile injectables manufacturing unit between March 9 and 17.

  • US regulator set to begin inspection of Dr Reddy's Srikakulam unit on March 27 Mar 24, 2017 03:50 PM IST

    US regulator set to begin inspection of Dr Reddy's Srikakulam unit on March 27

    Dr. Reddy’s said it spent about $35-40 million on remediation work that includes legal and professional charges.

  • 'Even in US and Europe, we haven't seen such orchestrated action by pharma cos' Mar 21, 2017 09:14 AM IST

    'Even in US and Europe, we haven't seen such orchestrated action by pharma cos'

    In an interview to Moneycontrol, David Keeling of McKinsey & Co says Indian pharmaceutical companies have made a lot of progress in terms of quality control, but there is still a long way to go.

  • After IT, Trump targets pharma; says will name US FDA chief soon Jan 31, 2017 08:29 PM IST

    After IT, Trump targets pharma; says will name US FDA chief soon

    For this he urges the US drug firms to come back and manufacture drugs in America rather than aboad. He also says he will ease tax rates to facilitate drug manufacturing in the country.

  • Indian pharma eyes pride of place, regulation Achilles heel Dec 22, 2016 12:22 PM IST

    Indian pharma eyes pride of place, regulation Achilles heel

    India is on track to cement its position next year as a source of safe, effective and quality medicines at affordable prices, but a "growing trust deficit" with the government and regulatory headwinds can pose a serious roadblock to this journey.

  • Awaiting $45 million from Venezuelan govt: Glenmark Pharma May 13, 2016 10:23 AM IST

    Awaiting $45 million from Venezuelan govt: Glenmark Pharma

    With the big product launch of Ezetimibe (a cholesterol-lowering drug), company's topline revenue to be over 25 percent, where 45 percent will be contributed by the US and 20-25 percent by the Indian business, says Glenn Saldanha, Chairman & MD of Glenmark Pharmaceuticals.

  • Thailand invites Indian pharma, IT cos for investment Mar 16, 2016 07:36 AM IST

    Thailand invites Indian pharma, IT cos for investment

    Government's expenditure on infrastructure investment and transportation development are some of the key factors driving the growth of Thailand's economy, Chotipal added.

  • Market consolidation not yet over; pharma good bet: Pros Mar 12, 2015 05:43 PM IST

    Market consolidation not yet over; pharma good bet: Pros

    Prakash Diwan of Altamount Capital Management is of the view that the market hasn't gone through the complete phase of consolidation yet and even though the market witnessed a bounce back today, it is unlikely to last for long.

  • US exports may drive top Indian pharma cos to grow in 2013 Feb 03, 2013 03:04 PM IST

    US exports may drive top Indian pharma cos to grow in 2013

    Top Indian pharma players will continue to grow strongly at over 20 per cent in 2013, primarily led by exports to the US market, India Ratings said in its outlook for the sector.

Sections